| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| Gene symbol | CD79A | Synonyms | IGA, IGAlpha, MB-1, MB1 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CD79a molecule | ||||
| GTO ID | GTC2880 |
| Trial ID | NCT05169489 |
| Disease | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD79A|CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | bbT369 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL) |
| Year | 2021 |
| Country | United States |
| Company sponsor | 2seventy bio |
| Other ID(s) | CRC-403 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||